Omeicos Therapeutics GmbH
3 clinical trials · Sponsor
◉ Watch Omeicos Therapeutics GmbH
| Record | Firm | Date |
|---|---|---|
| OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION) (NCT05972954) | Omeicos Therapeutics GmbH | 2023-05-22 |
| Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF) (NCT03906799) | Omeicos Therapeutics GmbH | 2019-03-19 |
| Safety and Pharmacokinetic Study of OMT-28 in Healthy Subjects (NCT03078738) | Omeicos Therapeutics GmbH | 2017-02-08 |
Track Omeicos Therapeutics GmbH automatically
Every clearance here is in the API, with alerts when new ones post.